How to Refer Patients to a Ketamine Therapy Clinic: What Providers Should Know

As a mental health provider, you may have worked with patients who remain stuck despite consistent psychotherapy, medication management, or other established treatments. At some point, you may begin considering whether a different treatment approach could help.

Ketamine therapy is one option that may enter this conversation, particularly for patients experiencing treatment-resistant depression.

However, knowing when to consider ketamine treatment and understanding how to refer patients to a ketamine therapy clinic are two different things.

The referral process involves more than identifying a nearby provider. It requires understanding patient eligibility, evaluating clinical safety, choosing an appropriate treatment model, and coordinating care.

This guide explains what providers should consider before making a ketamine therapy referral and how to support patients throughout the process.

When Should You Consider Referring a Patient for Ketamine Therapy?

Ketamine treatment is generally considered when established approaches have not provided adequate symptom relief. However, treatment resistance alone does not determine whether someone is an appropriate candidate.

Which Patients May Benefit From Ketamine Treatment?

A ketamine therapy referral may be worth discussing when patients experience:

  • Treatment-resistant depression: Persistent depressive symptoms despite adequate trials of conventional treatments.
  • Limited progress with existing care: Symptoms that continue to interfere with daily functioning despite consistent treatment.
  • Difficulty tolerating antidepressants: Medication-related adverse effects that limit available treatment options.
  • Interest in additional treatment approaches: Patients who want to explore alternatives after discussing their current treatment outcomes.

Ketamine is also being investigated for conditions such as PTSD, anxiety disorders, and OCD. However, the evidence varies by condition, and these applications require careful individualized consideration.

Importantly, referring a patient for an evaluation does not mean recommending ketamine as the definite next treatment.

When Might Ketamine Therapy Not Be Appropriate?

Not every patient experiencing persistent symptoms is suitable for ketamine treatment.

Medical and psychiatric considerations may include uncontrolled hypertension, certain cardiovascular conditions, active psychosis, a history of mania, substance misuse concerns, and pregnancy.

These factors do not all represent absolute contraindications, but they require appropriate assessment by a qualified medical professional.

The referring therapist’s role is to identify potential concerns and communicate relevant clinical information. The ketamine treatment provider remains responsible for determining medical eligibility.

What Should Providers Look for in a Ketamine Therapy Clinic?

Choosing the right clinic is an important part of the ketamine treatment referral process.

Two clinics may offer ketamine treatment but differ significantly in their screening procedures, therapeutic involvement, medical monitoring, and follow-up care.

Before referring patients for ketamine therapy, providers should understand how the clinic approaches safety and clinical responsibility.

Consider asking:

  • Who conducts medical and psychiatric evaluations before treatment?
  • What qualifications do the prescribing and administering clinicians hold?
  • How are blood pressure, dissociation, and other potential adverse effects monitored?
  • What emergency procedures are available?
  • How does the clinic communicate with existing mental health providers?
  • What follow-up support is available after treatment?

A clinic should also explain the treatment’s potential benefits, limitations, risks, and financial requirements.

Providers should be particularly cautious about programs that promise guaranteed outcomes or offer treatment without adequate screening and monitoring.

How Do Ketamine Treatment Models Differ?

Not all ketamine services follow the same clinical model.

IV ketamine treatment involves medically supervised intravenous administration, often focused on depressive symptom reduction. Its psychiatric use is off-label in the United States.

Intranasal esketamine (Spravato) is an FDA-approved treatment for specific depressive indications and must be administered under required clinical supervision.

Ketamine-Assisted Psychotherapy (KAP) incorporates psychotherapy into the treatment process, potentially including preparation, therapeutic support during sessions, and integration afterward.

KAP is distinct from medication-only treatment, and the evidence supporting psychotherapy’s additional contribution is still developing.

Understanding these differences helps providers identify which approach warrants further evaluation based on the patient’s needs, preferences, and treatment goals.

What Are the Challenges of Finding Ketamine Therapy Providers?

## What Are the Challenges of Finding Ketamine Therapy Providers?

One of the common challenges finding ketamine therapy providers is determining whether a clinic can offer the level of care a particular patient needs.

Availability alone does not establish clinical suitability.

Some providers focus primarily on medication administration, while others offer psychotherapy-supported treatment. Clinics may also differ in eligibility requirements, communication practices, and treatment settings.

Several practical considerations can influence a referral decision.

  • Treatment accessibility: Consider clinic location, transportation requirements, appointment availability, and whether the patient can attend the recommended treatment schedule.
  • Financial considerations: Ask about consultation fees, treatment costs, insurance coverage, and possible out-of-pocket expenses. Coverage varies by treatment type and insurance plan.
  • Continuity of care: Determine whether the clinic will communicate with the referring therapist, psychiatrist, or other involved providers with the patient’s authorization.
  • Therapeutic support: For patients seeking KAP, clarify who provides preparation and integration and whether their existing therapist can participate.

These questions are especially important when patients already have established therapeutic relationships.

A referral should expand treatment possibilities without unnecessarily disrupting the care and support the patient currently receives.

How Do You Refer a Patient to a Ketamine Therapy Clinic?

Once you have identified a potentially appropriate clinic, the next step is establishing a clear referral process.

Although requirements vary between providers, the following steps can help you make an informed referral and coordinate your patient’s care.

Step 1: Discuss Ketamine Treatment With Your Patient

Explain why ketamine therapy may be worth considering based on the patient’s symptoms, treatment history, and current progress. Discuss potential benefits, risks, and limitations, and clarify that a referral is an opportunity for further clinical evaluation rather than a guarantee of treatment.

Step 2: Contact the Ketamine Therapy Clinic

Reach out to the clinic to understand its referral requirements, available treatment options, and initial consultation process. Some clinics accept direct referrals from therapists or psychiatrists, while others allow patients to schedule an evaluation independently.

Confirm whether the clinic offers medication-focused treatment, Ketamine-Assisted Psychotherapy (KAP), or both.

Step 3: Share Relevant Patient Information

With appropriate patient consent, provide the clinical information needed to support the evaluation. Depending on the clinic’s requirements, this may include:

  • Current diagnoses and presenting symptoms
  • Previous treatments and responses
  • Medication history and current prescriptions
  • Relevant medical or psychiatric concerns
  • Treatment goals and reasons for referral
  • Referring provider’s contact information

Share only the information necessary for care coordination through appropriate, privacy-compliant channels.

Step 4: Allow the Clinic to Complete Its Clinical Assessment

The receiving clinic will generally conduct its own medical and psychiatric evaluation to determine whether ketamine treatment is appropriate.

If the patient is eligible, the treatment team will discuss suitable options, informed consent, safety protocols, and the proposed treatment plan.

A referral does not automatically mean the patient will be approved for ketamine therapy.

Step 5: Coordinate Follow-Up and Ongoing Care

Once the evaluation is complete, establish how the clinic and referring provider will communicate throughout treatment, with the patient’s authorization.

Clarify who will manage existing medications, monitor symptoms, provide psychotherapy or integration support, and respond to concerns between sessions.

Maintaining clear responsibilities helps support continuity of care while allowing the patient to explore an additional treatment option.

How Can Referring Providers Stay Involved in Ketamine-Assisted Care?

A ketamine therapy referral does not necessarily mean transferring the patient’s ongoing mental health care to another provider.

For patients already engaged in psychotherapy, maintaining that therapeutic relationship may be an important part of their treatment.

Depending on the treatment model, the existing therapist may continue providing psychotherapy, helping the patient prepare emotionally, and supporting integration following ketamine sessions.

Integration can involve exploring the patient’s experiences, identifying meaningful insights, and connecting these experiences to established therapeutic goals.

However, not every ketamine experience produces significant insights or lasting changes. Ongoing psychotherapy remains valuable regardless of the patient’s immediate response to treatment.

At The Ko-Op, we emphasize collaboration between medical professionals and psychotherapists, recognizing that therapists can play an important role before, during, and after ketamine treatment.

How Can Therapists Prepare to Incorporate KAP Into Their Practice?

For clinicians who want to take a more active role in Ketamine-Assisted Psychotherapy, understanding the practical aspects of treatment is an important next step.

This includes evaluating client candidacy, coordinating with prescribers, establishing informed consent, preparing clients for medicine sessions, and supporting integration.

These are also the areas we explore in The Ko-Op’s KAP Bootcamp for Psychotherapists, a live virtual training taking place November 12–13, 2026, offering 6 Continuing Education (CE) credits.

Led by Dr. Sophia Brandstetter and Diane Nachamkin, the training focuses on the clinical, ethical, and practical considerations of incorporating KAP into an existing psychotherapy practice.

Whether you are currently referring patients for ketamine treatment or considering offering KAP within your own practice, the goal is to understand how to support patients responsibly while maintaining continuity of care.

Explore the KAP Bootcamp and register here

JOIN OUR UPCOMING TRAINING

KAP Bootcamp for Psychotherapists

Take your understanding of Ketamine-Assisted Psychotherapy (KAP) from theory to practical clinical application. Join Dr. Sophia Brandstetter and Diane Nachamkin for the KAP Bootcamp for Psychotherapists, a live virtual training taking place on November 12–13, 2026.

Across 6 CE hours, this training will cover:

  • Client candidacy
  • Prescriber relationships
  • Informed consent
  • Preparation and medicine sessions
  • Integration and treatment planning
  • Legal and ethical considerations
  • Practical considerations for clinical practice

Live Virtual Training | November 12–13, 2026

REGISTER NOW

Picture of Sophia Brandstetter

Sophia Brandstetter

Dr. Sophia Brandstetter, LCSW, PsyD, specializes in complex and generational trauma. She is the founder of The Ko-Op, a Philadelphia-based center offering Ketamine-Assisted Psychotherapy. In addition to treating clients, she trains fellow clinicians in this modality. Her work integrates psychodynamic, mindfulness, and relational approaches with expanded states of consciousness for deep healing and transformation.